HER2 Support Group Forums - View Single Post - Study: Circadian’s anti-cancer therapy reduces tumour growth in animal models

News · 04-16-2010, 03:15 AM

Circadian Technologies Limited today released data demonstrating that its lead anti-cancer therapeutic, VGX-100, significantly inhibits tumour growth in a variety of different animal models (tumour xenografts) of human cancer.

More...

04-16-2010, 03:15 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,981	Study: Circadian’s anti-cancer therapy reduces tumour growth in animal models Circadian Technologies Limited today released data demonstrating that its lead anti-cancer therapeutic, VGX-100, significantly inhibits tumour growth in a variety of different animal models (tumour xenografts) of human cancer. More...